Literature DB >> 7780130

p15ink4B and p16ink4 gene inactivation in acute lymphocytic leukemia.

O Rasool1, M Heyman, L B Brandter, Y Liu, D Grandér, S Söderhäll, S Einhorn.   

Abstract

Malignant cells from 52 children with acute lymphocytic leukemia (ALL) were investigated for inactivation of the p15ink4B and p16ink4 genes and other genetic alterations on chromosome 9p21. Homozygous deletions of the p15ink4B and/or the p16ink4 genes were detected in 16 cases and a further 9 cases showed evidence of allelic loss either by hemizygous deletion or loss of heterozygosity (LOH) for 9p21 markers. Most cases had loss of both genes, but 5 patients had lost only p16ink4 and 2 cases had homozygous loss of p15ink4B only. Sequence analysis of all exons of p15ink4B and p16ink4 was performed in patients with hemizygous deletions or LOH for 9p21 markers. A frame shift mutation of p16ink4 exon 1 was shown in 1 case, whereas all other clones carried the wild-type sequence of p15ink4B and p16ink4 in the remaining allele. The data suggest that both the p15ink4B and p16ink4 genes can be inactivated in ALL. The existence of a hitherto undefined tumor-suppressor gene on chromosome 9p cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780130

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

Review 1.  The CDKN2A (p16) gene and human cancer.

Authors:  W D Foulkes; T Y Flanders; P M Pollock; N K Hayward
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

2.  p15(INK4b) plays a crucial role in murine lymphoid development and tumorigenesis.

Authors:  Kwame Osei-Sarfo; Ignacio Perez de Castro; Angel Pellicer
Journal:  Carcinogenesis       Date:  2012-01-06       Impact factor: 4.944

3.  Nonparametric estimation of LOH using Affymetrix SNP genotyping arrays for unpaired samples.

Authors:  Richard Huggins; Ling-Hui Li; You-Chin Lin; Alice L Yu; Hsin-Chou Yang
Journal:  J Hum Genet       Date:  2008-11-07       Impact factor: 3.172

4.  Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis.

Authors:  Wanhua Zhang; Pu Kuang; Ting Liu
Journal:  Ann Med       Date:  2019-02-14       Impact factor: 4.709

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.